Nomura Holdings Inc Madrigal Pharmaceuticals, Inc. Call Options Transaction History

Nomura Holdings Inc

  • $46 Billion
  • Q2 2025

Call Options

4 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2025

Aug 14, 2025
BUY
$267.56 - $340.8 $2.17 Million - $2.76 Million
8,100 New
8,100 $2.45 Million
Q4 2024

Feb 14, 2025
BUY
$202.45 - $354.85 $566,860 - $993,580
2,800 Added 46.67%
8,800 $2.72 Million
Q3 2024

Nov 14, 2024
SELL
$212.22 - $292.96 $212,220 - $292,960
-1,000 Reduced 14.29%
6,000 $1.27 Million
Q2 2024

Aug 14, 2024
BUY
$193.33 - $291.99 $1.35 Million - $2.04 Million
7,000 New
7,000 $1.96 Million

Others Institutions Holding MDGL

# of Institutions
356
Shares Held
23.2M
Call Options Held
738K
Put Options Held
473K
View Full List

About MADRIGAL PHARMACEUTICALS, INC.

MDGL Quotes by TradingView
  • Ticker MDGL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,103,400
  • Market Cap $7.58B
  • Description
  • Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...
More about MDGL
Track This Portfolio

Track Nomura Holdings Inc Portfolio

Follow Nomura Holdings Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Holdings Inc, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Holdings Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email